APA Citation

Mascarenhas, L., Albert, C., Federman, N., DuBois, S., Bielack, S., Orbach, D., & Gallego, S. (2025). Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Chicago Style Citation

Mascarenhas, Leo, Catherine Albert, Noah Federman, Steven DuBois, Stefan Bielack, Daniel Orbach, and Soledad Gallego. Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors. 2025.

MLA Citation

Mascarenhas, Leo, et al. Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors. 2025.

Warning: These citations may not always be 100% accurate.